Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991;84(3):233-6.
doi: 10.1007/BF01244973.

An evaluation of the partial dopamine agonist terguride regarding positive symptoms reduction in schizophrenics

Affiliations
Clinical Trial

An evaluation of the partial dopamine agonist terguride regarding positive symptoms reduction in schizophrenics

R Olbrich et al. J Neural Transm Gen Sect. 1991.

Abstract

Eleven schizophrenics (7 females) displaying an acute psychotic episode received the partial dopamine agonist terguride in doses up to 2 mg per day. Improvement in terms of positive symptoms reduction was observed in two cases only. In contrast, in a previous clinical trial targeted at negative schizophrenic symptoms, the majority of the patients appeared to have benefited from terguride application.

PubMed Disclaimer

References

    1. Pharmacopsychiatry. 1988 Nov;21(6):389-90 - PubMed
    1. J Neural Transm. 1983;57(4):309-15 - PubMed
    1. Life Sci. 1983 Jan 24;32(4):421-32 - PubMed

Publication types

LinkOut - more resources